Late outcome, therapy and systemic ventricular function in patients with a systemic right ventricle: data of the German National Register for Congenital Heart Defects.
Corinna LebherzMartin GerhardusAstrid Elisabeth LammersPaul HelmOktay TutarelUlrike BauerTanja BülowGunter KerstGerhard-Paul DillerNikolaus MarxPublished in: Cardiology in the young (2021)
A significant portion of patients with systemic right ventricle suffer from a relevant systemic ventricular dysfunction, systemic atrioventricular valve regurgitation, and arrhythmias. Despite this, medication for heart failure treatment is not universally used in this cohort. This emphasises the need for randomised trials in patient with systemic right ventricle.
Keyphrases
- heart failure
- mitral valve
- left ventricular
- pulmonary artery
- clinical trial
- aortic valve
- congenital heart disease
- mesenchymal stem cells
- coronary artery disease
- coronary artery
- atrial fibrillation
- emergency department
- oxidative stress
- drug induced
- quality improvement
- pulmonary arterial hypertension
- big data
- aortic stenosis
- catheter ablation
- ejection fraction
- bone marrow